As depicted in Figure 7, in addition to causing multiple diabetic complications, hyperglycemia in diabetic patients mediates cytoskeleton remodeling and thus enhances cell proliferation/metastasis via promoting actin de-polymerization by downregulating CRMP2 functional profile and thus contributes to CRC disease progression. Here, DPYSL2 is linked to Hyperglycemia.